Endocyte Raises $15 Million

Endocyte Inc., a West Lafayette, Ind.-based developer of receptor-targeted therapeutics for the treatment of cancer and autoimmune diseases, has raised $15 million in Series C-3 funding. Return backers include Sanderling Venture Partners, Burrill & Co., Triathlon Venture Partners, Blue Chip Venture Co., American Bailey Ventures and CID Capital. The post-money valuation was $77 million, according to VentureWire. Endocyte has raised around $61 million in total VC funding since 2001. www.endocyte.com